Back to search

Article

A serological assay to detect SARS-CoV-2 seroconversion in humans

2020-03-18

Abstract excerpt

SARS-Cov-2 (severe acute respiratory disease coronavirus 2), which causes Coronavirus Disease 2019 (COVID19) was first detected in China in late 2019 and has since then caused a global pandemic. While molecular assays to directly detect the viral genetic material are available for the diagnosis of acute infection, we currently lack serological assays suitable to specifically detect SARS-CoV-2 antibodies. Here we d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
90e80972-ef2a-59ce-8f28-865bfdd0e0d8
DOI
10.1101/2020.03.17.20037713
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A serological assay to detect SARS-CoV-2 seroconversion in humansDOI 10.1101/2020.03.17.20037713
Improved diagnosis of SARS-CoV-2 by using Nucleoprotein and Spike protein fragment 2 in quantitative dual ELISA testsSemantic proximity
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus AntibodiesSemantic proximity
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology testsSemantic proximity
SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalenceSemantic proximity
Emergency Response for Evaluating SARS-CoV-2 Immune Status, Seroprevalence and Convalescent Plasma in ArgentinaSemantic proximity
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patientsSemantic proximity
Identification of IgG antibody response to SARS-CoV-2 spike protein and its receptor binding domain does not predict rapid recovery from COVID-19Semantic proximity
High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assaySemantic proximity
Persistence of anti-SARS-CoV-2 antibodies in non-hospitalized COVID-19 convalescent health care workersSemantic proximity
A comprehensive antigen production and characterization study for easy-to-implement, highly specific and quantitative SARS-CoV-2 antibody assaysSemantic proximity
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?Semantic proximity
Clinical and laboratory considerations: Determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19Semantic proximity
Select a neighboring publication to make it the new centre.